Bayforest Capital’s Insmed INSM Stock Holding History

Bayforest Capital’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-663	Closed	-$70.7K	–	1035
2026 Q2	$70.7K	Buy	663 +337	+103%	+$40.8K	0.07%	529
2026 Q1	$53.3K	Sell	326 -1,095	-77%	-$168K	0.06%	541
2025 Q4	$247K	Buy	+1,421	New	+$259K	0.18%	214
2025 Q3	–	Sell	-4,098	Closed	-$412K	–	826
2025 Q2	$412K	Sell	4,098 -2,956	-42%	-$226K	0.18%	228
2025 Q1	$538K	Buy	7,054 +5,067	+255%	+$388K	0.23%	145
2024 Q4	$137K	Buy	+1,987	New	+$143K	0.17%	228

Other funds holding INSM

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Bayforest Capital's INSM Position: Q3 2026 in Review

Bayforest Capital sold out of Insmed (INSM) in Q3 2026, closing a stake of 663 shares — an estimated $70.7K sold.

Bayforest Capital first reported a position in INSM in Q4 2024 and held it in 6 quarters. The position peaked at $538K in Q1 2025. 547 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

Bayforest Capital reported no remaining Insmed position as of Q3 2026 after selling out during the quarter.
Bayforest Capital sold 663 Insmed shares in Q3 2026, an estimated $70.7K.
Bayforest Capital first reported a position in Insmed in Q4 2024 and held it in 6 quarters.
Bayforest Capital's Insmed position peaked at $538K in Q1 2025.
547 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Bayforest Capital's 13F filing for Q3 2026, filed 3 Nov 2026.